TCL Archive Phase III Five-Year Data Show Erbitux Increases Survival Of Head And Neck Cancer September 26, 2008
TCL Archive Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival March 28, 2014
TCL Archive OMB To Seek Rescission In ’79 Appropriation For NIH; NCI Cut Would BE $29 Million; FY 1980 Budget Request Will Be $912.7 Million December 8, 1978
